1 Liu, L. et al. Epidemiological and Clinical Characteristics of Patients With Coronavirus Disease-2019 in Shiyan City, China. Front Cell Infect Microbiol 10, 284, doi:10.3389/fcimb.2020.00284 (2020).
2 Huang, C. et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395, 497-506, doi:10.1016/S0140-6736(20)30183-5 (2020).
3 Phelan, A. L., Katz, R. & Gostin, L. O. The Novel Coronavirus Originating in Wuhan, China: Challenges for Global Health Governance. JAMA, doi:10.1001/jama.2020.1097 (2020).
4 Diagnosis and Treatment Protocol for Novel Coronavirus Pneumonia (Trial Version 7). Chin Med J (Engl) 133, 1087-1095, doi:10.1097/CM9.0000000000000819 (2020)
5 LI Fang-qin, Y. Y., WANG Dong,et al. Clinical laboratory monitoring and analysis of COVID-19. Journal of Yanan University 18, 10-13 ( 2020).
6 Faverio, P. & Sibila, O. New biomarkers in community-acquired pneumonia: Another step in improving outcome prediction. Respirology 22, 416-417, doi:10.1111/resp.13003 (2017).
7 X. T. L. J. X. F. e. a. Analysis of clinical characteristics of 49 patients with coronavirus disease 2019 in Jiangxi. Chinese Journal of Respiratory and Critical Care Medicine 19, 154-160 (2020).
8 Dong, E., Du, H. & Gardner, L. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect Dis 20, 533-534, doi:10.1016/S1473-3099(20)30120-1 (2020).
9 Docherty, A. B. et al. Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study. BMJ 369, m1985, doi:10.1136/bmj.m1985 (2020).
10 Sayoni Das, Krystyna Taylor, Matthew Pearson ,et al . Identification and Analysis of Shared Risk Factors in Sepsis and High Mortality Risk COVID-19 Patients.medRXiv;published online May 09, 2020.
11 Ohori Tatsuo, G., Riu Hamada, M., Gondo, T. & Hamada, R. Nomogram as predictive model in clinical practice. Gan To Kagaku Ryoho 36, 901-906 (2009).
12 Chen, N. et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet 395, 507-513, doi:10.1016/S0140-6736(20)30211-7 (2020).
13 LUO Meng, J. B., XU Hong-jie et al. Analysis of influencing factors of death in patients with COVID-19. Chinese Traditional and Herbal Drugs 51, 1450-1454 (2020)
14 Addeo, A., Obeid, M. & Friedlaender, A. COVID-19 and lung cancer: risks, mechanisms and treatment interactions. J Immunother Cancer 8, doi:10.1136/jitc-2020-000892 (2020).
15 Wrapp, D. et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science 367, 1260-1263, doi:10.1126/science.abb2507 (2020).
16 Chen, L. et al. Analysis of clinical features of 29 patients with 2019 novel coronavirus pneumonia. Zhonghua Jie He He Hu Xi Za Zhi 43, E005, doi:10.3760/cma.j.issn.1001-0939.2020.0005 (2020).
17 Perez-Guzman P.N., Daunt, A., Mukherjee, S. et al. Clinical characteristics and predictors of outcomes of hospitalised patients with COVID-19 in a London NHS Trust: a retrospective cohort study.doi: https://doi.org/10.25561/78613(2020).
18 Roham M, Abbaszadeh A, Zendehdel A, Momeni M, Mirzae N, Gholami M. Prognostic factors of sepsis rapid progression in patients admitted to Intensive Care Unit. Annals of Tropical Medicine and Public Health10,1770.doi:10.4103/ATMPH.ATMPH_646_17(2017).
19 WANG Yun,ZHAO Chang-cheng,GU Yan,et al. Analysis of Novel Coronavirus Pneumonia Related Blood Test Indexes in 80 Cases Journal of Clinical Transfusion and Laboratory Medicine;.2020.Published online :https://kns.cnki.net/kcms/detail/34.1239.R.20200313.1835.004.html
20 ZHOU Yuping, Z. C., WAN Xiwei,et al. Clinical characteristics and laboratory results of 3 886 patients with fever and cough in xianning area. Laboratory Medicine and Clinic 17,1541-1545(2020).
21 Zharnest, D. et al. Atypical presentation of congenital thrombotic thrombocytopenic purpura with large and small vessel disease: A case report. Pediatr Blood Cancer 67, e28316, doi:10.1002/pbc.28316 (2020).
22 Gawaz, M., Fateh-Moghadam, S., Pilz, G., Gurland, H. J. & Werdan, K. Platelet activation and interaction with leucocytes in patients with sepsis or multiple organ failure. Eur J Clin Invest 25, 843-851, doi:10.1111/j.1365-2362.1995.tb01694.x (1995).